Despite a century of development and refinement of insulin therapy, hypoglycaemia remains the most common complication, affecting virtually all people with type 1 diabetes and most of those with insulin-treated type 2 diabetes [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.